Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.
Opna Bio has raised $38.0M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Opna Bio's investors include Menlo Ventures, Longitude Capital, Northpond Ventures.
Opna Bio is headquartered in Epalinges, Switzerland.
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.
Opna Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Opna Bio — Funding & Investors." VCBacked, November 21, 2022, https://www.vcbacked.co/company/opna-bio. Accessed November 13, 2026.
VCBacked. (2022). Opna Bio — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/opna-bio
{{cite web |title=Opna Bio — Funding & Investors |url=https://www.vcbacked.co/company/opna-bio |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Opna Bio? Request a listing update